BridgeMD
New treatment option for Thyroid Cancer
Official title Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.
ClinicalTrials.gov ID: NCT06149637
What this study is testing
- What it's testing
- The objective of this study is to compare shoulder and neck morbidity and the effectiveness of cervical lateral nodal dissection in patients with differentiated thyroid cancer and lateral metastases between the anterior and posterior approaches to the sternocleidomastoid muscle (SCM)
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Patients ≥ 18 years.
- Patients with macroscopic lymph node involvement identified by physical examination, imaging or intraoperatively in lateral neck.
- Patients with microscopic nodal involvement confirmed by FNAB (definition by the pathologist of suspected or confirmed metastatic papillary carcinoma...
- Candidates for lateral lymph node dissection due to suspected or confirmed disease metastatic lymph nodes as defined by the treating surgeon.
- Patients requiring or not requiring thyroidectomy and/or central dissection concomitant with the dissection
You likely can't join if
- Patients with a history of previous neck dissection
- Histological confirmation of medullary or anaplastic carcinoma
- Previous spinal nerve injury
The study team makes the final eligibility decision.
Where it's taking place
- Medellín, Antioquia, Colombia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Medellín, Antioquia, Colombia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.